Walleye Trading LLC Cel Sci Corp Call Options Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	SELL	$2.58 - $4.99 $29,412 - $56,886	-11,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $234,228 - $458,920	-59,600 Reduced 83.94%	11,400 $45,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $12.82 $305,300 - $551,260	43,000 Added 153.57%	71,000 $504,000
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $194,820 - $318,495	25,500 Added 1020.0%	28,000 $308,000
Q4 2020 Feb 16, 2021	BUY	$11.05 - $16.62 $27,625 - $41,550	2,500 New	2,500 $29,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $33.4M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.